Saccharomyces cerevisiae as a platform for vaccination against bovine mastitis - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement
Article Dans Une Revue Vaccine Année : 2024

Saccharomyces cerevisiae as a platform for vaccination against bovine mastitis

Patricia Cunha
  • Fonction : co premier-auteur
  • PersonId : 1203149
Florence Gilbert
Anne Pinard
  • Fonction : Auteur
  • PersonId : 1158048
Alain Deslis
  • Fonction : Auteur
  • PersonId : 1158049
S. Barbey
Pierre Germon
Pascal Rainard

Résumé

Mastitis is a major issue for the dairy industry. Despite multiple attempts, the efficacy of available mastitis vaccines is limited and this has been attributed to their incapacity to trigger robust cell-mediated immunity. Yeasts have recently been identified as promising antigen vectors capable of inducing T-cell responses, surpassing the antibody-biased mechanisms elicited by conventional adjuvanted vaccines. In this study, we combine in vitro, ex vivo, and in vivo approaches to evaluate the potential of the yeast Saccharomyces cerevisiae as a platform for novel vaccines against bovine mastitis. We demonstrate that S. cerevisiae is safe for intramuscular and intramammary immunisation in dairy cows. Vaccination resulted in a significant increase of IFNγ and IL-17 responses against the yeast platform but not against the vaccine antigen. These observations highlight that strategies to counterbalance the immunodominance of S. cerevisiae antigens are necessary for the development of successful vaccine candidates.
Fichier principal
Vignette du fichier
2024_Danzelle_Vaccine_vol-42_art-126385.pdf (4.23 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04741220 , version 1 (17-10-2024)

Licence

Identifiants

Citer

Célya Danzelle, Patricia Cunha, Pablo Gomes Noleto, Florence Gilbert, Kamila Reis Santos, et al.. Saccharomyces cerevisiae as a platform for vaccination against bovine mastitis. Vaccine, 2024, 42 (26), pp.126385. ⟨10.1016/j.vaccine.2024.126385⟩. ⟨hal-04741220⟩
16 Consultations
4 Téléchargements

Altmetric

Partager

More